MedPath

Neurofeedback During Eating for Bulimia Nervosa

Not Applicable
Recruiting
Conditions
Bulimia Nervosa
Registration Number
NCT05614024
Lead Sponsor
Icahn School of Medicine at Mount Sinai
Brief Summary

The purpose of this study is to examine the effects of noninvasive prefrontal cortex (PFC) neurofeedback during eating in women with bulimia nervosa (BN) using a wearable brain imaging device, functional near-infrared spectroscopy (fNIRS). The investigators will examine how this training may influence inhibitory control and BN symptoms.

Detailed Description

The purpose of this study is to examine the effects of PFC neurofeedback during eating in women with bulimia nervosa (BN) using fNIRS. Specifically, the study aims 1) to demonstrate ventrolateral PFC (vlPFC) neurofeedback target engagement in women with BN using fNIRS; and 2) to link changes in PFC activation to changes in inhibitory control and eating-related symptoms.

Data will be collected from women with BN who will be randomly assigned to one of two group conditions (real or sham-control neurofeedback during eating). Participation includes a phone screening assessment, psychodiagnostic assessment, one in-person evaluation, one neurofeedback session, behavioral tasks, online questionnaires before and after the neurofeedback session, and a remote follow-up assessment.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Functional near-infrared spectroscopy (fNIRS)-measured neural activation and connectivityapproximately 1 hour

The investigators will evaluate changes in PFC neural activation and connectivity as a function of neurofeedback.

Number of loss-of-control eating and purging episodes2 weeks

Frequency of loss-of-control eating and purging episodes. Participants will self-report on how often loss-of-control eating and purging episodes occur using electronic daily diaries in the week before and the week after the neurofeedback session.

Go/no-go task performance2 weeks

Participants will complete a go/no-go task 1 week before and 1 week after the neurofeedback session to measure inhibitory control.

Participants behavioral performance on the go/no-go task will be determined by the percentage of incorrect responses made as they are prompted to react to different pictorial stimuli. Participants' percentages of error can range from 0% to 100%. A higher percentage indicates a lower behavioral performance on the task.

Severity of loss-of-control eating scale2 weeks

Severity of loss-of-control eating. Participants will rate the severity of their feelings of control over eating and purging episodes on a Likert-type scale from 0-10. Higher score indicates greater severity of loss of control.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Center for Computational Psychiatry at the Icahn School of Medicine at Mount Sinai

🇺🇸

New York, New York, United States

Center for Computational Psychiatry at the Icahn School of Medicine at Mount Sinai
🇺🇸New York, New York, United States
Laura A. Berner
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.